Zech L, Gahrton C, Killander D, Franzén S, Haglund U
Blood. 1976 Nov;48(5):687-96.
The chromosomes of bone marrow cells from ten patients with polycythemia vera (PV) were identified by Q-, G-, and C-banding techniques. Four of the patients had received no treatment with cytotoxic drugs, while three had received 32P only and the other three, in addition, had received busulfan or busulfan and procarbazine. One 73-yr-old male patient treated with venesection only for 4 yr lacked the Y chromosome and had a deletion of the long arm of chromosome 20 (20q-) in all cells investigated. One of the other three patients who had received no drugs had a chromosome abnormality, but only in 1 of 19 identifiable metaphases. However, the abnormality was the same (+9) as the most common one in treated patients. In the group of treated patients, an extra chromosome 9 (+9) was found in three patients, an extra chromosome 8 (+8) in one, and a deletion of the long arm of one chromosome 20 (20q-) in one patient. Multiple aberrations in addition to the extra chromosome 9 were found in one patient in whom the disease had transformed into acute myeloblastic leukemia. The finding of identical chromosomal aberrations (20q- and +9, respectively) in two patients who had received no drugs and in four patients who had received 32P and busulfan or procarbazine favors the view that these aberrations are specifically associated with the disease and not induced by the drugs. With the exception of the patient with acute myeloblastic leukemia, all other patients are alive 1-11 mo after chromosome analyses and 1-229 mo after diagnosis.
采用Q显带、G显带和C显带技术对10例真性红细胞增多症(PV)患者的骨髓细胞染色体进行了鉴定。其中4例患者未接受过细胞毒性药物治疗,3例仅接受过32P治疗,另外3例除32P外还接受过白消安或白消安加丙卡巴肼治疗。1例仅接受放血治疗4年的73岁男性患者,在所检测的所有细胞中均缺乏Y染色体,且存在20号染色体长臂缺失(20q-)。另外3例未接受过药物治疗的患者中,有1例存在染色体异常,但仅在19个可识别的中期细胞中的1个细胞中出现。不过,该异常(+9)与接受治疗患者中最常见的异常相同。在接受治疗的患者组中,3例患者发现额外的9号染色体(+9),1例发现额外的8号染色体(+8),1例发现1条20号染色体长臂缺失(20q-)。1例疾病已转化为急性髓细胞白血病的患者除额外的9号染色体外还发现了多种畸变。在2例未接受药物治疗的患者以及4例接受32P和白消安或丙卡巴肼治疗的患者中发现了相同的染色体畸变(分别为20q-和+9),这支持了这些畸变与该疾病特异性相关而非由药物诱导的观点。除急性髓细胞白血病患者外,所有其他患者在染色体分析后1 - 11个月以及诊断后1 - 229个月仍存活。